Showing results (91-100 of 692) with videos related to
Sort By:
Pageof 70
European Journal of Pharmacology|March 18, 1986
Species variations in RU 24969 interactions with non-5-HT1A binding sitesR E Heuring, J R Schlegel, S J PeroutkaBiological Psychiatry|July 15, 1990
Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sitesA Hamik, D Oksenberg, C Fischette, et al.Molecular Pharmacology|April 1, 1992
Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptorsX M Guan, S J Peroutka, B K KobilkaCephalalgia : an International Journal of Headache|February 1, 1997
The comorbid association of migraine with osteoarthritis and hypertension: complement C3F and Berkson's biasS J Peroutka, S C Price, K W JonesJournal of Neurochemistry|April 1, 1995
The third intracellular loop of the 5-hydroxytryptamine2A receptor determines effector coupling specificityD Oksenberg, S Havlik, S J Peroutka, et al.Life Sciences|January 1, 1990
6-substituted tricyclic partial ergoline compounds are selective and potent 5-hydroxytryptamine1A receptor agentsJ L Slaughter, M A Harrington, S J PeroutkaPsychopharmacology|January 1, 1988
R(-)-2,5-dimethoxy-4-77 bromoamphetamine [77Br-R(-)DOB]: a novel radioligand which labels a 5-HT binding site subtypeS S Wang, C A Mathis, S J PeroutkaLife Sciences|January 1, 1991
5-benzyloxytryptamine: a relatively selective 5-hydroxytryptamine 1D/1B agentS J Peroutka, B G McCarthy, X M GuanBiochemical Pharmacology|June 1, 1991
Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptorsA V Deliganis, P A Pierce, S J PeroutkaJournal of Neurology, Neurosurgery, and Psychiatry|April 1, 1985
Calcium channel antagonism by pizotifenS J Peroutka, S B Banghart, G S AllenPageof 70